1. Oncogenic regulation of tumor metabolic reprogramming
   Míriam Tarrado-Castellarnau et al, 2016, Oncotarget CrossRef
2. Phytochemicals: Current Understandings of the Modern Therapeutic Approaches for Hepatocellular Carcinoma
   Austin Cook et al, 2020, Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers CrossRef
3. What Chinese Medicine Can Do for Liver Cancer?
   Feiyu Chen et al, 2018, Liver Cancer CrossRef
4. miRNA as molecular target of polyphenols underlying their biological effects
   Dragan Milenkovic et al, 2013, Free Radical Biology and Medicine CrossRef
5. Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma
   Ning Wang et al, 2014, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
6. MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy
   Ming Hong et al, 2015, Cancers CrossRef
7. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
   Fabrizio Bronte et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
8. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma
   Jihan Huang et al, 2020, The American Journal of Chinese Medicine CrossRef
9. Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis
   Manon Ruffin et al, 2020, Cellular and Molecular Life Sciences CrossRef
10. The Na+/Cl−-Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis
    Mohd Omar F. Sikder et al, 2018, The AAPS Journal CrossRef
11. Amino Acid Transporters in Cancer and Their Relevance to “Glutamine Addiction”: Novel Targets for the Design of a New Class of Anticancer Drugs
    Yangzom D. Bhutia et al, 2015, Cancer Research CrossRef
12. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms
    Xuanbin Wang et al, 2015, Journal of Integrative Medicine CrossRef
13. WITHDRAWN: Skullcapflavone I has a potent anti-pancreatic cancer activity by targeting miR-23a
    Jing Cui et al, 2019, Life Sciences CrossRef
14. Skullcapflavone I has a potent anti‐pancreatic cancer activity by targeting miR‐23a
    Jing Cui et al, 2020, BioFactors CrossRef
15. MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth
    Ting-Fang Lo et al, 2013, PLoS ONE CrossRef
16. Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics
    Sahreen Sumaira et al, 2024, Non-coding RNA Research CrossRef
17. Urtica dioica extract suppresses miR-21 and metastasis-related genes in breast cancer
    Behzad Mansoori et al, 2017, Biomedicine & Pharmacotherapy CrossRef
18. Mechanism underlying the effect of Pulsatilla decoction in hepatocellular carcinoma treatment: a network pharmacology and in vitro analysis
    Kuijie Liu et al, 2023, BMC Complementary Medicine and Therapies CrossRef
19. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects
    Ming Hong et al, 2015, International Journal of Molecular Sciences CrossRef
20. Hepatocellular carcinoma and miRNAs: An in silico approach revealing potential therapeutic targets for polyphenols
    Luiz Gustavo de Almeida Chuffa et al, 2022, Phytomedicine Plus CrossRef
21. Metabolic Regulation in Mitochondria and Drug Resistance
    Yue Pan et al, 2017, Mitochondrial DNA and Diseases CrossRef
22. Antiinflammatory and Hepatoprotective Medicinal Herbs as Potential Substitutes for Bear Bile
    Sandra Appiah et al, 2017, Neurobiology of Chinese Herb Medicine CrossRef
23. Regulation of miRNAs by herbal medicine: An emerging field in cancer therapies
    Ali Mohammadi et al, 2017, Biomedicine & Pharmacotherapy CrossRef
24. Promotion of quality standard of Chinese herbal medicine by the integrated and efficacy-oriented quality marker of Effect-constituent Index
    Yin Xiong et al, 2018, Phytomedicine CrossRef
25. Correlation between miR-23a and onset of hepatocellular carcinoma
    Lidao Bao et al, 2014, Clinics and Research in Hepatology and Gastroenterology CrossRef
26. Suppression of Vascular Endothelial Growth Factor via Inactivation of Eukaryotic Elongation Factor 2 by Alkaloids in Coptidis rhizome in Hepatocellular Carcinoma
    Hor Yue Tan et al, 2014, Integrative Cancer Therapies CrossRef
27. On Broken Ne(c)ks and Broken DNA: The Role of Human NEKs in the DNA Damage Response
    Isadora Pavan et al, 2021, Cells CrossRef
28. Platelet miRNAs and cardiovascular diseases
    Eduardo Fuentes et al, 2015, Life Sciences CrossRef
29. Amino Acid Transporters and Glutamine Metabolism in Breast Cancer
    Yoon Cha et al, 2018, International Journal of Molecular Sciences CrossRef
30. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
    Luying He et al, 2022, Frontiers in Pharmacology CrossRef
31. MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3
    Guangxian Xu et al, 2013, BMC Cancer CrossRef
32. RETRACTED: LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway
    Chao Fu et al, 2018, Neurotherapeutics CrossRef
33. microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
    Ning Wang et al, 2018, Cancers CrossRef